SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-15-096189
Filing Date
2015-03-18
Accepted
2015-03-18 08:12:04
Documents
7
Period of Report
2015-03-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d894451d8k.htm 8-K 41752
2 EX-10.1 d894451dex101.htm EX-10.1 37825
3 EX-10.2 d894451dex102.htm EX-10.2 48203
4 EX10.3 d894451dex103.htm EX-10.3 85862
5 EX-99.1 d894451dex991.htm EX-99.1 19354
6 EX-99.2 d894451dex992.htm EX-99.2 15139
7 GRAPHIC g894451g80c06.jpg GRAPHIC 10224
  Complete submission text file 0001193125-15-096189.txt   263820
Mailing Address 70 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 2
Business Address 70 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 2 (216) 523-5000
Actavis plc (Filer) CIK: 0001578845 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36867 | Film No.: 15708773
SIC: 2834 Pharmaceutical Preparations